Page last updated: 2024-09-04

n-acetyltalosaminuronic acid and Cancer of Pancreas

n-acetyltalosaminuronic acid has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Burkhart, RA; Burns, WR; Cameron, JL; Delitto, DJ; Habib, JR; He, J; Ivey, GD; Kinny-Köster, B; Lafaro, KJ; Narang, A; Shoucair, S; Shubert, CR; Thompson, EL; Wolfgang, CL; Zheng, L1

Other Studies

1 other study(ies) available for n-acetyltalosaminuronic acid and Cancer of Pancreas

ArticleYear
Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy.
    World journal of surgery, 2022, Volume: 46, Issue:11

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Humans; Neoadjuvant Therapy; Pancreatectomy; Pancreatic Neoplasms; Retrospective Studies; Uronic Acids

2022